(Q44351059)

2 December 2017

title

The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. (English)

1 reference

2 December 2017

0 references

6

1 reference

2 December 2017

9

1 reference

2 December 2017

Patrick Laurent

1

1 reference

2 December 2017

Jerome A J Becker

2

1 reference

2 December 2017

Olga Valverde

3

1 reference

2 December 2017

Catherine Ledent

4

1 reference

2 December 2017

Alban de Kerchove d'Exaerde

5

1 reference

2 December 2017

Rafael Maldonado

7

1 reference

2 December 2017

Gilbert Vassart

8

1 reference

2 December 2017

language of work or name

English

0 references

publication date

20 November 2005

1 reference

2 December 2017

1 reference

2 December 2017

volume

8

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

1735-1741

1 reference

https://scigraph.springernature.com/pub.10.1038/nn1585

2 December 2017

exact match

0 references

cites work

Clinical pharmacology of opioids for pain

1 reference

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

21 January 2018

1 reference

Neuropeptide FF and modulation of pain

21 January 2018

1 reference

Pharmacology of nociceptin and its receptor: a novel therapeutic target

21 January 2018

1 reference

Utilizing functional genomics to identify new pain treatments : the example of nociceptin

21 January 2018

1 reference

Opioid-modulating peptides: mechanisms of action

21 January 2018

1 reference

Blood concentrations of vasopressin, neuropeptide FF and prolactin are increased by high-dose right unilateral ECT.

21 January 2018

1 reference

Neuropeptide FF, pain and analgesia

21 January 2018

1 reference

A prolactin-releasing peptide in the brain

21 January 2018

1 reference

Alternative role for prolactin-releasing peptide in the regulation of food intake.

21 January 2018

1 reference

Prolactin-releasing peptide as a novel stress mediator in the central nervous system.

21 January 2018

1 reference

Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids

21 January 2018

1 reference

Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception

21 January 2018

1 reference

Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms.

21 January 2018

1 reference

Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice

21 January 2018

1 reference

Strain differences in the analgesic and reinforcing action of morphine in mice.

21 January 2018

1 reference

New approaches to study the development of morphine tolerance and dependence

21 January 2018

1 reference

An opponent-process theory of motivation: I. Temporal dynamics of affect.

21 January 2018

1 reference

FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

21 January 2018

1 reference

Orphanin FQ/nociceptin blocks acquisition of morphine place preference.

21 January 2018

1 reference

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain

21 January 2018

1 reference

Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor

21 January 2018

1 reference

Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats

21 January 2018

1 reference

Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups.

21 January 2018

1 reference

Involvement of CB1 cannabinoid receptors in emotional behaviour.

21 January 2018

1 reference

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

21 January 2018

1 reference

Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

21 January 2018

1 reference

A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation

21 January 2018

1 reference

7 January 2021

Central administration of prolactin-releasing peptide stimulates oxytocin release in rats

1 reference

7 January 2021

In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats

1 reference

7 January 2021

Spinal analgesic activity of orphanin FQ/nociceptin and its fragments

1 reference

7 January 2021

Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.

1 reference

7 January 2021

Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene

1 reference

7 January 2021

The role of CCK2 receptors in the homeostasis of the opioid system

1 reference

7 January 2021

Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN1585

1 reference

Dimensions Publication ID

2 December 2017

1026947745

0 references

1 reference